HIF1α leads to the pathogenesis in CML cells by upregulating their downstream genes (Notch 2/4/Ikaros/SIRT1/Foxo-3a/p53, etc.). The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.